Answer Addiction

Tag: Veterans Affairs

  • Veterans Affairs To Offer Ketamine-Based Nasal Spray For Depression Treatment

    Veterans Affairs To Offer Ketamine-Based Nasal Spray For Depression Treatment

    The recently approved drug is said to relieve symptoms of depression as well as suicidal ideation in a short timeframe. 

    Veterans Affairs officials are now allowing VA doctors to prescribe Spravato, a medically viable variation of ketamine, to service members who suffer from depression.

    The drug has been known to beat some symptoms of depression extraordinarily quickly—taking just a few short days, or hours instead of weeks. Suicidal thoughts have been seen to dissipate in a timeframe as short as 40 minutes.

    “That first skyrocket up was my first infusion,” said Matthew Ayo, a 23-year-old who underwent ketamine treatment. “I went from severe depression to no depression symptoms.”

    Doctors will be able to prescribe Spravato only if at least two other antidepressants have been tried and failed to produce results.

    “We’re pleased to be able to expand options for Veterans with depression who have not responded to other treatments,” said VA secretary Robert Wilkie.

    Of the United States’ 20 million veterans, an estimated 14%—or 2.8 million veterans—are diagnosed with depression. Of those veterans, one-third to one-half may suffer from treatment-resistant depression, which is why it was so critical to find something new and fast.

    “Controlled clinical trials that studied the safety and efficacy of this drug, along with careful review through the FDA’s drug approval process, including a robust discussion with our external advisory committees, were important in our decision to approve this treatment,” said Dr. Tiffany Farchione, acting director of the FDA’s Center for Drug Evaluation and Research Division of Psychiatry Products.

    Spravato isn’t without side effects, however—including sedation, blood pressure spikes, and dissociation, including feeling paralysis or out-of-body sensations. Ironically, misuse may lead to suicidal thoughts and behaviors. Hence, the FDA approved the drug for VA prescriptions with restrictions.

    Veterans approved for the treatment would use the nasal spray under medical supervision. Afterwards, medical staff would monitor the patient for two hours. The patient would have to return for two doses a week for the first month, and one dose every two or three weeks in the months following. To prevent potential misuse, there is no option for home treatment.

    Ketamine’s new role is a far cry from its former life as “Special K,” an anesthetic that saw use on the dance floor as well as the battlefield. In the latter usage, military medical staff found that those prescribed with ketamine for pain also had fewer symptoms of PTSD.

    View the original article at thefix.com

  • Vets Turn To Medical Pot, Despite The VA's Policy

    Vets Turn To Medical Pot, Despite The VA's Policy

    The VA remains focused on studying the drug’s “problems of use” instead of its “therapeutic potential.”

    Once a month, the veterans’ hall in Santa Cruz, California, is home to an unlikely meeting, where dozens of former service members line up to receive a voucher for free cannabis products from local distributors. 

    “I never touched the stuff in Vietnam,” William Horne, 76, a retired firefighter, told The New York Times. “It was only a few years ago I realized how useful it could be.” 

    The VA medical system does not allow providers to discuss or prescribe medical marijuana, since the drug remained banned under federal law, which governs the VA.

    However, up to a million veterans who get healthcare through the system have taken matters into their own hands, using marijuana to relieve symptoms of PTSD, pain and other medical condition associated with combat. 

    “We have a disconnect in care,” said Marcel Bonn-Miller, a psychologist who worked for years at the veterans hospital in Palo Alto, California, and now teaches at the University of Pennsylvania medical school. “The VA has funded lots of marijuana studies, but not of therapeutic potential. All the work has been related to problems of use.” 

    This means that veterans like those in Santa Cruz can end up self-medicating with cannabis without any medical oversight. 

    A bill proposed this spring would mandate that the VA study cannabis for treating PTSD and chronic pain. 

    “I talk to so many vets who claim they get benefits, but we need research,” said Representative Tim Walz, a Democrat from Minnesota, who introduced the bill along with Phil Roe, a doctor and Republican from Tennessee. “You may be a big advocate of medical marijuana, you may feel it has no value. Either way, you should want the evidence to prove it, and there is no better system to do that research than the VA.” 

    Still, VA spokesperson Curt Cashour said the bill is not enough to change the department’s policies. 

    “The opportunities for VA to conduct marijuana research are limited because of the restrictions imposed by federal law,” he said. “If Congress wants to facilitate more federal research into Schedule 1 controlled substances such as marijuana, it can always choose to eliminate these restrictions.” 

    Former Secretary of Veteran’s Affairs David J. Shulkin said that it’s time the system looked into the potential benefits of cannabis. 

    “We have an opioid crisis, a mental health crisis, and we have limited options with how to address them, so we should be looking at everything possible,” he said. Although two small studies are currently being done at the VA, Shulkin would like to see more. 

    “In a system as big as ours, that’s not much, certainly not enough,” he said.

    View the original article at thefix.com